169 related articles for article (PubMed ID: 34445936)
1. Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells.
Kim HR; Park JH; Lee SH; Kwack SJ; Lee J; Kim S; Yoon S; Kim KB; Lee BM; Kacew S; Kim HS
J Toxicol Environ Health A; 2022 Jan; 85(1):29-42. PubMed ID: 34445936
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of dendropanoxide isolated from Dendropanax morbifera against cisplatin-induced acute kidney injury via the AMPK/mTOR signaling pathway.
Park YJ; Kim KS; Park JH; Lee SH; Kim HR; Lee SH; Choi HB; Cao S; Kumar V; Kwak JH; Kim HS
Food Chem Toxicol; 2020 Nov; 145():111605. PubMed ID: 32750447
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
[TBL] [Abstract][Full Text] [Related]
4. Dendropanoxide Attenuates High Glucose-induced Oxidative Damage in NRK-52E Cells via AKT/mTOR Signaling Pathway.
Lee SH; Kim JR; Shin JK; Lee JS; Kim YM; Kwak JH; Kim HS
Planta Med; 2024 Apr; 90(4):256-266. PubMed ID: 38040033
[TBL] [Abstract][Full Text] [Related]
5. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
6. NMR and LCMS analytical platforms exhibited the nephroprotective effect of Clinacanthus nutans in cisplatin-induced nephrotoxicity in the in vitro condition.
Mahmod II; Ismail IS; Alitheen NB; Normi YM; Abas F; Khatib A; Rudiyanto ; Latip J
BMC Complement Med Ther; 2020 Oct; 20(1):320. PubMed ID: 33092571
[TBL] [Abstract][Full Text] [Related]
7. Age-related differences in kidney injury biomarkers induced by cisplatin.
Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
[TBL] [Abstract][Full Text] [Related]
8. Hepatic damage exacerbates cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Kim JS; Son JY; Kim KS; Lim HJ; Ahn MY; Kwack SJ; Kim YM; Lee KY; Lee J; Lee BM; Kim HS
J Toxicol Environ Health A; 2018; 81(11):397-407. PubMed ID: 29557720
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
[TBL] [Abstract][Full Text] [Related]
10. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.
Zhou Y; Xu H; Xu W; Wang B; Wu H; Tao Y; Zhang B; Wang M; Mao F; Yan Y; Gao S; Gu H; Zhu W; Qian H
Stem Cell Res Ther; 2013 Apr; 4(2):34. PubMed ID: 23618405
[TBL] [Abstract][Full Text] [Related]
11. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
[TBL] [Abstract][Full Text] [Related]
12. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
13. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
Jiao X; Cai J; Yu X; Ding X
Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
[TBL] [Abstract][Full Text] [Related]
14. Role of myo-inositol in acute kidney injury induced by cisplatin.
Xie YH; Wang L; Li ML; Gong ZC; Du J
Toxicology; 2023 Nov; 499():153653. PubMed ID: 37863467
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.
Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K
J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo.
Okamoto K; Saito Y; Narumi K; Furugen A; Iseki K; Kobayashi M
Eur J Pharmacol; 2020 Oct; 884():173339. PubMed ID: 32726655
[TBL] [Abstract][Full Text] [Related]
17. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
18. Effect of ginsenoside Rh
Qi Z; Li W; Tan J; Wang C; Lin H; Zhou B; Liu J; Li P
Phytomedicine; 2019 Aug; 61():152862. PubMed ID: 31048124
[TBL] [Abstract][Full Text] [Related]
19. Porous Se@SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1.
Li X; Wang Q; Deng G; Liu Y; Wei B; Liu X; Bao W; Wang Q; Wu S
Toxicol Appl Pharmacol; 2019 Oct; 380():114704. PubMed ID: 31400413
[TBL] [Abstract][Full Text] [Related]
20. Role of the increase in p21 in cisplatin-induced acute renal failure in rats.
Miyaji T; Kato A; Yasuda H; Fujigaki Y; Hishida A
J Am Soc Nephrol; 2001 May; 12(5):900-908. PubMed ID: 11316848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
